What happened in research today, from the outlets and labs that report it.
STAT
Verdict: NotableIn data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis occurred.
The American Diabetes Association has issued two explanations, two reviews and an apology over its June convention.
An MS treatment from Novartis cut by a third the rates of relapses compared to a standard treatment.
Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, a new analysis finds.
Space Force considering options: public-private, federal installation, state land.